NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

This post is for paying subscribers only

Already have an account? Sign in.

HNI Acquires Steelcase for ~$2.2B, Creating a Furniture Industry Powerhouse.

This strategic merger unites complementary portfolios and dealer networks, aiming to enhance customer reach across diverse segments.

08/04/2025 · 10:15 AM
HNI
/ Read more

Feed↓

Mineralys Shares Fall After FDA Accepts NDA for Lorundrostat – Explore-OSA Misses Primary Endpoint but Delivers Strong BP Reduction
03/09/2026 · 5:57 PM

Mineralys Shares Fall After FDA Accepts NDA for Lorundrostat – Explore-OSA Misses Primary Endpoint but Delivers Strong BP Reduction

Mineralys receives FDA acceptance of NDA for lorundrostat for hypertension. PDUFA target date: December 22, 2026. Explore-OSA missed primary endpoint but demonstrated meaningful BP reduction.

/ Subscriber only
Flying Taxis Get Green Light: Joby, Archer, Beta Jump as U.S. Launches Major eVTOL Pilot Projects
03/09/2026 · 5:19 PM

Flying Taxis Get Green Light: Joby, Archer, Beta Jump as U.S. Launches Major eVTOL Pilot Projects

Joby, Archer, and Beta stocks surge after DOT selects them for Trump's eVTOL air taxi pilot program — electric flying taxis set to test in 26 states starting summer 2026.

/ Subscriber only
Vertex’s Povetacicept Hits Primary + All Secondary Endpoints in Phase 3 IgAN Trial
Featured/ 03/09/2026 · 4:49 PM

Vertex’s Povetacicept Hits Primary + All Secondary Endpoints in Phase 3 IgAN Trial

Vertex Pharmaceuticals' povetacicept succeeds in Phase 3 RAINIER trial for IgA nephropathy with 52% proteinuria reduction. Positive safety data and FDA submission planned soon.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe